Neuroone Medical Technologies (NMTC) Return on Equity (2016 - 2025)
Historic Return on Equity for Neuroone Medical Technologies (NMTC) over the last 12 years, with Q4 2025 value amounting to 1.01%.
- Neuroone Medical Technologies' Return on Equity rose 28100.0% to 1.01% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.01%, marking a year-over-year increase of 28100.0%. This contributed to the annual value of 0.91% for FY2025, which is 25700.0% up from last year.
- Neuroone Medical Technologies' Return on Equity amounted to 1.01% in Q4 2025, which was up 28100.0% from 0.47% recorded in Q3 2025.
- In the past 5 years, Neuroone Medical Technologies' Return on Equity ranged from a high of 0.47% in Q3 2025 and a low of 6.43% during Q3 2024
- In the last 5 years, Neuroone Medical Technologies' Return on Equity had a median value of 1.22% in 2021 and averaged 1.93%.
- In the last 5 years, Neuroone Medical Technologies' Return on Equity tumbled by -40900bps in 2024 and then surged by 59500bps in 2025.
- Neuroone Medical Technologies' Return on Equity (Quarter) stood at 0.96% in 2021, then decreased by -5bps to 1.0% in 2022, then crashed by -152bps to 2.53% in 2023, then plummeted by -51bps to 3.83% in 2024, then surged by 74bps to 1.01% in 2025.
- Its Return on Equity was 1.01% in Q4 2025, compared to 0.47% in Q3 2025 and 1.15% in Q2 2025.